"They’re going to express in vivo! And that’s so much less invasive than dumb, old-fashioned gene therapy. That’s been the critical limiting factor, a permanent cheap method of delivery. And if we can do amyloids as well as dopamine and neurotrophic factors ... I mean, transfer all those loads congruently into live neural tissue.... Well, I don’t have to tell you what that means."